Smith & Nephew: FDA approves Versajet for burn indication

By Lisa Kerner

Erie, Pa., May 30 - Smith & Nephew's Advanced Wound Management division said the Food and Drug Administration approved a label amendment to include burn indication clearance for its advanced surgical wound management product, Versajet.

The FDA had already approved Versajet for the surgical debridement (removal of dead tissue) in other wounds, including chronic and acute wounds.

The Versajet Hydrosurgery System is a specialized waterjet-powered surgical device that enables surgeons to grasp, cut and remove damaged tissue and contaminants without collateral tissue damage, according to a news release.

Smith & Nephew is a London-based medical technology business. Its Advanced Wound Management division is based in Hull, U.K.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.